Logo image of OHRP

Ohr Pharmaceutical Inc. (OHRP) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:OHRP -

5.39
+1.25 (+30.19%)
Last: 7/12/2019, 8:00:00 PM
5.51
+0.12 (+2.23%)
After Hours: 7/12/2019, 8:00:00 PM

OHRP Key Statistics, Chart & Performance

Key Statistics
Market Cap15.25M
Revenue(TTM)N/A
Net Income(TTM)-8.94M
Shares2.83M
FloatN/A
52 Week High6.28
52 Week Low1.6
Yearly Dividend0
Dividend Yield0%
EPS(TTM)-0.97
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


OHRP short term performance overview.The bars show the price performance of OHRP in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60 80 100

OHRP long term performance overview.The bars show the price performance of OHRP in the last 1, 2 and 3 years. 1 year 2 years 3 years 5 10 15 20 25

The current stock price of OHRP is 5.39 null. In the past month the price increased by 50.98%. In the past year, price increased by 28.33%.

Ohr Pharmaceutical Inc. / OHRP Daily stock chart

OHRP Latest News, Press Relases and Analysis

6 years ago - By: Benzinga - Mentions: CVM EMKR HOOK ICAD ...
News Image
6 years ago - By: Analyst Ratings - Mentions: ERBB IMUC UEC CNAT
News Image
6 years ago - By: Benzinga - Mentions: EMKR HOOK ILMN INFY ...
News Image
6 years ago - By: Seeking Alpha - Mentions: ILMN HOOK OASM MDGS ...
News Image
6 years ago - By: Analyst Ratings - Mentions: ANTH ACUR TRTC FCEL
News Image
6 years ago - By: Analyst Ratings - Mentions: ERBB KPTI DVAX ANTH
News Image
6 years ago - By: Analyst Ratings - Mentions: ERBB KPTI DVAX ONCS
News Image
6 years ago - By: Seeking Alpha - Mentions: OASM XBIO TYME GOL ...
News Image

About OHRP

Company Profile

Ohr Pharmaceutical, Inc. is a pharmaceutical company. It is focused on the development of novel therapeutics for the treatment of cancer cachexia, wet form of age-related macular degeneration and ophthalmic neovascularization disorders. Ohr Pharmaceutical, Inc. is headquartered in New York.

Company Info

Ohr Pharmaceutical Inc.

800 THIRD AVENUE 11TH FLOOR

NEW YORK NY 10022

CEO: Jason Slakter

Phone: 212-682-8452

Ohr Pharmaceutical Inc. / OHRP FAQ

What does OHRP do?

Ohr Pharmaceutical, Inc. is a pharmaceutical company. It is focused on the development of novel therapeutics for the treatment of cancer cachexia, wet form of age-related macular degeneration and ophthalmic neovascularization disorders. Ohr Pharmaceutical, Inc. is headquartered in New York.


What is the stock price of Ohr Pharmaceutical Inc. today?

The current stock price of OHRP is 5.39 null. The price increased by 30.19% in the last trading session.


Does Ohr Pharmaceutical Inc. pay dividends?

OHRP does not pay a dividend.


What is the ChartMill rating of Ohr Pharmaceutical Inc. stock?

OHRP has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


OHRP Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to OHRP. When comparing the yearly performance of all stocks, OHRP is one of the better performing stocks in the market, outperforming 98.94% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

OHRP Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to OHRP. OHRP may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

OHRP Financial Highlights

Over the last trailing twelve months OHRP reported a non-GAAP Earnings per Share(EPS) of -0.97. The EPS decreased by -259.26% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -92.83%
ROE -99.27%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-700%
Sales Q2Q%N/A
EPS 1Y (TTM)-259.26%
Revenue 1Y (TTM)N/A

OHRP Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next Y95.09%
Revenue Next YearN/A

OHRP Ownership

Ownership
Inst Owners0%
Ins Owners51.19%
Short Float %N/A
Short RatioN/A